Application of DEPA score to 20 PRP preparations in which biological characteristics are available on publications indexed in PubMed
| DEPA classification | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dose of injected platelets (billions) | Efficiency of the process (platelet recovery rate %) | Purity of the PRP (relative composition in platelets %) | |||||||||
| A | >5 | Very high dose | A | >90 | High | A | >90 | Very pure PRP | |||
| B | 3–5 | High dose | B | 70–90 | Medium | B | 70–90 | Pure PRP | |||
| C | 1–3 | Medium dose | C | 30–70 | Low | C | 30–70 | Heterogeneous PRP | Final DEPA score | ||
| D | <1 | Low dose | D | <30 | Poor | D | <30 | Whole blood PRP | |||
| Kaux et al15 | Homemade | D | 0.74 | Low dose | C | 46.2 | Low | A | 90.3 | Very pure PRP | DCA |
| Curasan | D | 0.55 | Low dose | C | 32.4 | Low | A | 97.7 | Very pure PRP | DCA | |
| Plateltex | D | 0.23 | Low dose | D | 19.4 | Poor | B | 87.5 | Pure PRP | DDB | |
| GPS II | C | 2.28 | Medium dose | D | 22.8 | Poor | D | 6.0 | Whole blood PRP | CDD | |
| RegenLab | D | 0.95 | Low dose | B | 79.3 | Medium | A | 97.5 | Very pure PRP | DBA | |
| Castillo et al14 | Cascade | C | 2.43 | Medium dose | C | 67.5 | Low | B | 81.5 | Pure PRP | CCB |
| GPS III | C | 2.48 | Medium dose | D | 22.6 | Poor | D | 27.0 | Whole blood PRP | CDD | |
| Magellan | B | 3.41 | High dose | C | 65.8 | Low | C | 60.4 | Heterogeneous PRP | BCC | |
| Magalon et al12 | Selphyl | D | 0.95 | Low dose | C | 59.5 | Low | B | 73.9 | Pure PRP | DCB |
| RegenPRP | D | 0.99 | Low dose | C | 61.7 | Low | C | 46.0 | Heterogeneous PRP | DCC | |
| Mini GPS III | C | 2.56 | Medium dose | C | 34.6 | Low | C | 51.8 | Heterogeneous PRP | CCC | |
| Arthrex | C | 1.06 | Medium dose | C | 48.0 | Low | B | 81.0 | Pure PRP | CCB | |
| Homemade | C | 1.81 | Medium dose | C | 30.2 | Low | B | 80.7 | Pure PRP | CCB | |
| Kushida et al14 | JP200 | C | 1.04 | Medium dose | D | 26.0 | Poor | D | 19.6 | Whole blood PRP | CDD |
| GLO | D | 0.64 | Low dose | C | 37.4 | Low | C | 38.2 | Heterogeneous PRP | DCC | |
| Magellan | A | 5.43 | Very high dose | C | 45.3 | Low | C | 32.9 | Heterogeneous PRP | ACC | |
| Kyocera | B | 3.12 | High dose | B | 78.1 | Medium | D | 29.4 | Whole blood PRP | BBD | |
| Selphyl | D | 0.21 | Low dose | D | 13.1 | Poor | A | 99.7 | Very pure PRP | DDA | |
| MyCells | D | 0.98 | Low dose | C | 48.8 | Low | B | 87.3 | Pure PRP | DCB | |
| Dr. Shin | D | 0.78 | Low dose | C | 45.9 | Low | D | 18.8 | Whole blood PRP | DCD | |
DEPA, Dose of injected platelets, Efficiency of production, Purity of the PRP, Activation of the PRP; PRP, platelet-rich plasma.